Table 3.
Multivariate Cox regression analysis for 30-day mortality
| All patients | ADHF | No ADHF | ||||
|---|---|---|---|---|---|---|
| Variable | HR for 30-day mortality | P-value | HR for 30-day mortality | P-value | HR for 30-day mortality | P-value |
| Copeptin a | 4.58 (2.29 to 9.13) | < 0.0001 | 6.51 (2.83 to 14.95) | < 0.0001 | 1.87 (0.29 to 12.12) | 0.51 |
| BNP a | 1.42 (0.71 to 2.86) | 0.32 | 0.76 (0.23 to 2.50) | 0.65 | 2.28 (0.49 to 10.67) | 0.3 |
| NT-proBNP a | 3.17 (1.49 to 6.71) | 0.003 | 3.84 (1.15 to 12.89) | 0.029 | 5.32 (1.1 to 25.76) | 0.038 |
| Adjusted model including NT to proBNP or Copeptin | ||||||
| Copeptin a | 3.88 (1.94 to 7.77) | < 0.001 | 5.99 (2.55 to 14.07) | < 0.0001 | 1.23 (0.17 to 9.14) | 0.84 |
| NT-proBNP a | 2.74 (1.27 to 5.93) | 0.01 | 2.78 (0.78 to 10.60) | 0.11 | 5.26 (1.07 to 25.79) | 0.041 |
Adjusted for age, gender, history of heart failure, glomerular filtration rate, diabetes, systolic blood pressure. a log-transformed to achieve normal distribution. BNP, B-type natriuretic peptide; NT-proBNP, N-terminal pro-B-type natriuretic peptide; HR, hazard ratio.